
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
EDITORIAL article
Front. Med. , 04 October 2024
Sec. Family Medicine and Primary Care
Volume 11 - 2024 | https://doi.org/10.3389/fmed.2024.1496449
This article is part of the Research Topic Advances in Chronic Pain Treatment View all 11 articles
Editorial on the Research Topic
Advances in chronic pain treatment
Chronic pain is a multifaceted condition that affects millions globally (1), often persisting beyond 3 months and significantly impairing individuals' quality of life (2). In recent decades, significant advances have been made in understanding the pathophysiology of chronic pain, laying the groundwork for the development of new therapies and therapeutic approaches. This progress has been largely driven by advances in neuroscience, providing a deeper understanding of how the brain and central nervous system process pain (3). The development of neuroimaging techniques has allowed scientists to observe directly the alterations in brain activity associated with chronic pain, identifying abnormal patterns of neural activation and desynchronization that perpetuate pain perception (4, 5).
This growing understanding of chronic pain has led to the integration of multiple disciplines in its approach, from medicine and psychology to biotechnology and engineering (6). This multidisciplinary approach is crucial for addressing the complexity of this condition, enabling the development of strategies that not only focus on relieving pain but also address its underlying causes, thus optimizing long-term outcomes for patients (7).
Understanding the neurophysiological mechanisms underlying chronic pain remains a priority within the field. Pinilla-Fernández et al. explore the neurobiological underpinnings of chronic neuropathic pain using advanced neuroimaging techniques. Where they quantified the difference in brain metabolite concentrations in whiplash-associated disorders (WAD) within the anterior cingulate and dorsolateral prefrontal cortex, and identified key metabolites associated with chronic neuropathic pain components during chronic WAD.
Additionally, Diao et al. employ a genetic approach to investigate modifiable risk factors in the development and progression of knee osteoarthritis. Through a Mendelian randomization study, they highlight the causal relationships between these risk factors and the disease, underscoring the importance of addressing modifiable elements in both preventive and therapeutic strategies. Together, these studies reinforce the need for a multifaceted approach to managing chronic pain, integrating neurophysiological insights with a focus on modifiable risk factors to optimize patient outcomes.
One of the central themes in recent advances in chronic pain treatment is the role of neuromodulation in managing chronic pain conditions. Chang et al. provide a comprehensive review of the effectiveness of transcranial alternating current stimulation (tACS) in managing chronic pain. While results vary across different studies, this review highlights the potential of tACS as a non-invasive neuromodulatory tool, particularly for conditions resistant to conventional therapies. Moreover, Escobar-Sánchez et al. explore the long-term effects of high-frequency stimulation (HFS) on pain and sensitivity in healthy subjects. Their study illustrates significant bilateral changes in mechanical and thermal sensitivity after HFS, particularly in cold sensitivity, which persisted long after the stimulation ended. These findings suggest that demographic characteristics, such as age and gender, may influence the efficacy of neuromodulatory interventions. As research continues to explore pain mechanisms, these insights will be crucial for developing more targeted and effective therapies.
The exploration of innovative therapies and technologies remains a critical focus in the current scientific landscape. Li et al. review the latest developments in biomimetic nanotechnology for drug delivery, particularly emphasizing its application in treating rheumatoid arthritis. They highlight the potential of biomimetic nano-systems to revolutionize the treatment of chronic inflammatory conditions by enhancing the precision and efficiency of drug delivery. This approach could significantly improve the management of diseases like rheumatoid arthritis, where targeted drug delivery is essential to improve therapeutic efficacy, minimize systemic side effects, and thus optimize patient outcomes.
Additionally, Doménech-García et al. investigate the complex interplay between placebo and nocebo effects in invasive treatments, such as percutaneous needle electrolysis and dry needling, for patients with patellar tendinopathy. Their research sheds light on the intricate psychological factors involved in chronic pain management, demonstrating how patient expectations can profoundly influence treatment outcomes.
The importance of personalized approaches in treating chronic pain is another significant theme within recent research. Escobar-Sánchez et al. highlight how different stimulation modalities can lead to variable changes in pain perception and sensitivity, emphasizing the necessity of tailoring pain management strategies to the specific characteristics of each patient. Similarly, Sreckovic et al. explore the role of peripheral nerve blocks in managing chronic post-surgical pain (CPSP) after knee arthroplasty. Their findings suggest that nerve blocks, such as the adductor canal block and interspace between the popliteal artery and capsule of the posterior knee block, significantly reduce opioid consumption and the incidence of CPSP, demonstrating that personalized regional analgesia can effectively improve postoperative outcomes and reduce long-term pain.
On the other hand, Del Piccolo et al. introduce the INTEGRO protocol, an innovative integrated psychotherapeutic intervention designed for fibromyalgia (FM) management. This protocol combines Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and somatic experiential techniques to address the complex, multifaceted nature of FM. Through a personalized approach that includes psychoeducation, emotion regulation, and self-efficacy enhancement, the INTEGRO protocol has demonstrated its effectiveness in reducing FM-related pain and improving the health-related quality of life in patients. Moreover, La Touche et al. introduce the BioPMovQ, a novel instrument designed to assess the relationship between pain and movement from a biobehavioral perspective. These studies collectively highlight the critical need for personalized therapeutic approaches in chronic pain treatment, emphasizing the role of individualized strategies in optimizing patient outcomes.
In addition to personalized treatments, it is also relevant to highlight the integration of theoretical knowledge into clinical practice advances. Zhai et al. revisit and refine the theory of trigger points and their role in musculoskeletal pain, offering a comprehensive review that emphasizes the importance of understanding muscle pain patterns in clinical practice considering biomechanics, kinesiology and compensatory mechanisms. Their work advocates for a more nuanced application of trigger point theory in clinical settings, emphasizing that a deeper grasp of these mechanisms can lead to improved patient outcomes.
The articles featured in this analysis collectively advance our understanding of chronic pain and its management. By integrating neuromodulation, personalized therapies, theoretical insights, and innovative technologies, these studies offer a comprehensive overview of the current landscape in chronic pain treatment. The findings presented here not only deepen our understanding of chronic pain but also pave the way for future research and clinical applications that could significantly enhance patient care and outcomes.
RF-P: Writing – review & editing, Writing – original draft. ML-S: Writing – original draft, Writing – review & editing. CG: Writing – original draft, Writing – review & editing.
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
1. Zimmer Z, Fraser K, Grol-Prokopczyk H, Zajacova A. A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors. Pain. (2022) 163:1740–50. doi: 10.1097/j.pain.0000000000002557
2. Hadi MA, McHugh GA, Closs SJ. Impact of chronic pain on patients' quality of life: a comparative mixed-methods study. J Patient Exp. (2019) 6:133–41. doi: 10.1177/2374373518786013
3. Chen ZS. Decoding pain from brain activity. J Neural Eng. (2021) 18:051002. doi: 10.1088/1741-2552/AC28D4
4. Bosma RL, Hemington KS, Davisa KD. Using magnetic resonance imaging to visualize the brain in chronic pain. Pain. (2017) 158:1192. doi: 10.1097/j.pain.0000000000000941
5. Martucci KT, MacKey SC. Neuroimaging of pain: human evidence and clinical relevance of central nervous system processes and modulation. Anesthesiology. (2018) 128:1241–54. doi: 10.1097/ALN.0000000000002137
6. Driscoll MA, Kerns RD. Integrated, team-based chronic pain management: bridges from theory and research to high quality patient care. Adv Exp Med Biol. (2016) 904:131–47. doi: 10.1007/978-94-017-7537-3_10
Keywords: chronic pain, neurophysiological mechanisms, risk factors, neuromodulation, personalized & precision medicine (PPM), biobehavioral, movement
Citation: Ferrer-Peña R, Lipnik-Stangelj M and Goicoechea C (2024) Editorial: Advances in chronic pain treatment. Front. Med. 11:1496449. doi: 10.3389/fmed.2024.1496449
Received: 14 September 2024; Accepted: 23 September 2024;
Published: 04 October 2024.
Edited and reviewed by: Arch Mainous, University of Florida, United States
Copyright © 2024 Ferrer-Peña, Lipnik-Stangelj and Goicoechea. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Raúl Ferrer-Peña, ZHJyYXVsZmVycmVyQGdtYWlsLmNvbQ==
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.